相关实验视频

Updated: Sep 19, 2025

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations

Published on: March 29, 2017

诊断和管理的沃尔登斯特罗姆的巨球蛋白血症

Steven P Treon^1,2, Shayna Sarosiek^1,2, Jorge J Castillo^1,2

¹Bing Center for Waldenstrom's Macroglobulinemia, Dana Farber Cancer Institute, Boston, Massachusetts, USA.

Hematological oncology

|June 15, 2025

概括

沃尔登斯特罗姆巨型球蛋白血症 (WM) 是一种罕见的淋巴瘤. 像MYD88和CXCR4这样的基因突变影响治疗结果和对BTK抑制剂的耐药性,指导个性化治疗策略.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学遗传学是一个

背景情况:

沃尔登斯特罗姆巨型球蛋白病 (WM) 是一种由IgM分泌的淋巴细胞性淋巴瘤.
在WM中常见的遗传变异包括MYD88 (95%-97%) 和CXCR4 (30%-40%) 突变,在高达30%的患者中观察到TP53变异,特别是在先前治疗的病例中.
突变的MYD88通过HCK激活了BTK等信号通路,从而促进了淋巴瘤细胞的存活.

研究的目的:

为了审查沃尔登斯特罗姆巨型球蛋白血症的遗传景观.
讨论MYD88,CXCR4和TP53突变对疾病特征和治疗反应的影响.
根据基因组资料概述WM的当前和新兴治疗策略.

主要方法:

在WM中遗传突变的文献综述.
对参与WM病变发生的信号通路的分析.
对BTK抑制剂和新药的治疗反应的评估.

主要成果:

特定的CXCR4突变,特别是无意义变异,与高粘度和对共价BTK抑制剂 (cBTK-i) 耐药性有关.
cBTK-i扎努布鲁丁尼布在WM患者中表现出有效性,这些患者患有野生型MYD88,突变CXCR4或改变TP53.
新兴疗法包括皮尔托布鲁丁尼,BGB-16673,venetoclax和sonrotoclax是cBTK-i进展的患者的选择.

结论:

基因组分析对理解WM和指导治疗决策至关重要.
对WM的治疗算法应该包括遗传突变,疾病特征和患者的并发症.
针对性疗法和组合疗法的进展为WM患者提供了更好的结果.

关键词:

这就是BTK的BTK.在CXCR4中,CXCR4是最常见的.在MYD8888中,你会发现什么?这就是TP53的特点.沃尔登斯特罗姆的巨型球蛋白血症淋巴细胞性淋巴瘤淋巴细胞性淋巴瘤

更多相关视频

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

相关概念视频

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...